Envestnet Asset Management Inc. Lowers Position in Chemed Co. (NYSE:CHE)

Envestnet Asset Management Inc. lessened its stake in Chemed Co. (NYSE:CHE - Free Report) by 1.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 76,428 shares of the company's stock after selling 1,408 shares during the quarter. Envestnet Asset Management Inc. owned 0.51% of Chemed worth $40,492,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Resona Asset Management Co. Ltd. acquired a new stake in Chemed in the fourth quarter valued at $1,368,000. Prudential PLC boosted its position in shares of Chemed by 17.6% in the 4th quarter. Prudential PLC now owns 3,521 shares of the company's stock worth $1,865,000 after buying an additional 528 shares in the last quarter. Trexquant Investment LP acquired a new stake in Chemed in the 4th quarter valued at about $6,172,000. Headlands Technologies LLC purchased a new position in Chemed during the 4th quarter valued at about $230,000. Finally, Geode Capital Management LLC raised its position in Chemed by 1.5% during the fourth quarter. Geode Capital Management LLC now owns 340,409 shares of the company's stock worth $180,654,000 after acquiring an additional 4,966 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the stock. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. Royal Bank of Canada raised their price target on Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research report on Friday, March 14th.

Remove Ads

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of the stock in a transaction on Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the transaction, the chief executive officer now owns 101,679 shares of the company's stock, valued at $62,566,139.07. This represents a 0.97 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. 3.32% of the stock is owned by corporate insiders.

Chemed Stock Performance

CHE stock traded down $12.42 during trading on Tuesday, hitting $588.27. The stock had a trading volume of 106,219 shares, compared to its average volume of 97,299. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $625.09. The stock has a market cap of $8.60 billion, a price-to-earnings ratio of 29.73, a price-to-earnings-growth ratio of 2.15 and a beta of 0.49. The company's 50 day moving average price is $584.60 and its two-hundred day moving average price is $567.87.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were given a dividend of $0.50 per share. The ex-dividend date was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. Chemed's dividend payout ratio (DPR) is currently 10.05%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.